Related Experiment Video
Updated: Jan 19, 2026
08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
5.4K
Occupational bladder cancer: from cohort study to biologic molecular marker
Kazumasa Matsumoto1, Akira Irie, Takefumi Satoh
1Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa, Japan. kazuamsa@cd5.so-net.ne.jp
Summary
Early detection of occupational bladder cancer using molecular markers shows promise. Traditional screening methods have limitations, but new biologic markers may improve monitoring and reduce mortality from carcinogen exposure.
Area of Science:
- Occupational health
- Oncology
- Molecular epidemiology
Background:
- Occupational exposure to carcinogens poses a risk for bladder cancer.
- Traditional screening methods like hematuria testing, urinary cytology, and cystoscopy have limitations in reducing bladder cancer mortality.
- New molecular substances show potential as bladder cancer screening markers.
Purpose of the Study:
- To review epidemiologic cohort studies, hematuria screening, and biologic molecular markers for bladder cancer related to occupational carcinogenicity.
- To explore the potential of new screening and monitoring strategies for occupational bladder cancers.
Main Methods:
- Review of epidemiologic cohort studies.
- Analysis of hematuria screening data.
- Evaluation of biologic molecular markers for bladder cancer.
- Consideration of occupational carcinogenicity and latency periods.
Main Results:
- Traditional screening methods have demonstrated limitations in reducing bladder cancer mortality.
- Biologic molecular markers show potential for early detection and monitoring of occupational bladder cancers.
- New cases of occupational bladder cancer are anticipated due to long latency periods.
Conclusions:
- Biologic markers offer a promising avenue for screening and monitoring occupational bladder cancers.
- Advances in molecular techniques are crucial for improving outcomes in occupational bladder cancer.
- Further research into molecular markers is warranted for effective prevention and management.
